1 of 3 listed pharmas spends 40% of their sales into SG&A

Published: 2017-08-21 14:25:58

Updated: 2017-08-21 14:25:58

It was observed 1 of 3 listed pharmaceutical companies had a SG&A(selling, general and administrative) expense/sales ratio more than 40%. The ratio that is higher than other industries has worked as an obstacle of increasing profitability.

Yakup Shinmoon(www.yakup.com) analyzed 60 KOSPI and KOSDAQ listed pharmaceutical companies’ 2017 2^nd quarter reports, the analysis showed they had a 29.5% S...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.